Cite
HARVARD Citation
Wang, Y. et al. (2018). A seven-color panel including CD34 and TdT could be applied in >97% patients with T cell lymphoblastic leukemia for minimal residual disease detection independent of the initial phenotype. Leukemia research. pp. 12-19. [Online].